UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

The bipartisan agreement highlighted a growing consensus that PBM business models are flawed ... Newt Gingrich praised Mike Johnson’s performance as speaker. Victoria Spartz, on the other ...

CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?

In addition to adjudicating pharmacy charges, the PBM provides the payer with access to a nationwide network of pharmacy providers that are contracted with to provide services and drug products at ...

Douglas Hoey, said in a statement, “PBM reform would rein in the big health insurance lobby, save taxpayers $5 billion, and throw a lifeline to the thousands of small, family-owned pharmacies ...

The report notes that large employers' perceptions about PBM performance have not changed much over the past 5 years. Employers continue to be more satisfied with core PBM services and ...

A new lawsuit challenges Minnesota’s law for regulating pharmacy benefit managers, a group of companies that structure drug benefits within health insurance plans that critics have accused of ...

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been ...

This remarkable stability is attributable to PBMs. The PBM business model dictates that they are adversaries to drug manufacturers and pharmacies. PBMs affect the revenues of branded drug ...